Internal Medicine · Grand Rapids, MI
NPI
1043284219
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3230 Eagle Park Dr NE, Suite 101
Grand Rapids, MI, 49525
Phone (616) 954-0600
Medicare paid, 2024
$86K
5,666 services
Medicare patients, 2024
23
Average age 69
Drug cost, 2024
$825K
28 prescriptions
Company payments, 2025
$210
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Khan J Nedd was code 96365 (intravenous infusion, hydration), 12 times for 12 patients. In total Khan J Nedd billed 5,666 services in 27 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 96365 Intravenous Infusion, Hydration | Office | 12 | 12 | $42.10 | $505 |
By year: 2022 $748K for 60,001 services; 2023 $333K for 22,325 services; 2024 $86K for 5,666 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 15 | 12 | $7.87 | $118 |
Medicare prescription drug claims, 2024
In 2024, the drug Khan J Nedd prescribed most often to Medicare patients was Galafold (Migalastat Hcl), with 26 prescriptions and refills. In total Khan J Nedd wrote 28 Medicare prescriptions that cost $825K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Galafold Migalastat Hcl | 26 | 26 | Under 11 | $825K |
Brand drugs: 26 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Khan J Nedd $210 ($210 in general payments such as food, travel and fees) from 5 companies. The largest payer was Genzyme Corporation with $132.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.